Approval · Notice of Compliance 23727 · 2020
SUBLOCADE: Notice of Compliance 23727
Issued June 4, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23727
- Date
- June 4, 2020
- Company
- Indivior Uk LimitedHull, United Kingdom
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- To update and change the design of the syringe labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUBLOCADE | Not yet assigned | — |
Medicinal ingredients
- BUPRENORPHINE 100 MG per 0.5ML
- BUPRENORPHINE 300 MG per 1.5ML